Cognetivity Neurosciences (STU:1UB) Pretax Margin %: -7,035.00% (As of Oct. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cognetivity Neurosciences Pretax Margin %?

Cognetivity Neurosciences STU:1UB Pretax Margin % is -7,035.00% as of Oct. 2023.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Cognetivity Neurosciences's Pre-Tax Income for the three months ended in Oct. 2023 was €-1.41 Mil. Cognetivity Neurosciences's Revenue for the three months ended in Oct. 2023 was €0.02 Mil. Therefore, Cognetivity Neurosciences's pretax margin for the quarter that ended in Oct. 2023 was -7,035.00%.

The historical rank and industry rank for Cognetivity Neurosciences's Pretax Margin % or its related term are showing as below:


STU:1UB's Pretax Margin % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 4.19
* Ranked among companies with meaningful Pretax Margin % only.

Cognetivity Neurosciences  (STU:1UB) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Cognetivity Neurosciences Pretax Margin % Related Terms


Cognetivity Neurosciences Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Cognetivity Neurosciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cognetivity Neurosciences Pretax Margin % Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Pretax Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -16,580.65

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -5,719.35 -47,500.00 -9,457.14 -7,035.00

STU:1UB vs VEEV, GEHC, HQY: Pretax Margin % Comparison

For the Health Information Services subindustry, Cognetivity Neurosciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences Pretax Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's Pretax Margin % falls into.



Cognetivity Neurosciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Cognetivity Neurosciences's Pretax Margin for the fiscal year that ended in Jan. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Jan. 2023 )/Revenue (A: Jan. 2023 )
=-5.14/0.031
=-16,580.65 %

Cognetivity Neurosciences's Pretax Margin for the quarter that ended in Oct. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Oct. 2023 )/Revenue (Q: Oct. 2023 )
=-1.407/0.02
=-7,035.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -7,035.00% mean?
Cognetivity Neurosciences (STU:1UB) has a Pretax Margin % of -7,035.00% as of Oct. 2023. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Cognetivity Neurosciences and its competitors.
Is Cognetivity Neurosciences' Pretax Margin % too high?
Cognetivity Neurosciences' current Pretax Margin % is -7,035.00%.
How does Cognetivity Neurosciences' Pretax Margin % compare to VEEV and GEHC?
Cognetivity Neurosciences' Pretax Margin % of -7,035.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median Pretax Margin % is 4.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.19, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Cognetivity Neurosciences and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cognetivity Neurosciences's current Pretax Margin % is -7,035.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cognetivity Neurosciences stock overvalued right now?
Cognetivity Neurosciences (STU:1UB) has a current Pretax Margin % of -7,035.00%. The current Pretax Margin % is -7,035.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Cognetivity Neurosciences (STU:1UB), the current Pretax Margin % is -7,035.00% as of Oct. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cognetivity Neurosciences Business Description

Address 800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.